Recent advances in cell adhesion molecule (CAM) research and development: Targeting CAMs for therapeutic and diagnostic applications

Drugs of the Future

Volumn 21, Issue 3, 1996, Pages 283-289

  Mousa, Shaker A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; PADGEM PROTEIN; SELECTIN B; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CANCER; DRUG DESIGN; DRUG TARGETING; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; THROMBOSIS;

EID: 0029994497     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Cox, D , Aoki, T., Seki, J., Motoyama, Y , Yoshida, K. The pharmacology of the integrins. Med Res Rev 1994, 14 (2): 195-228.
2. Albelda, S.M., Buck, C.A. Integrins and other cell adhesion molecules. FASEB J 1990, 4: 2868-80.
3. Cook, N.S., Kottirsch, G., Zerwes, H. Platelet glycoprotein IIb/IIIa antagonists. Drugs Fut 1994, 19 (2): 135-59.
4. 2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotem IIb/IIIa in patients with unstable angina pectoris. J Clin Invest 1990, 86: 651-9.
5. Mousa, S A., Bozarth, J.M., Forsythe, M.S. et al. Anti-platelet efficacy and specificity of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Cardiology 1993, 83: 374-82.
6. Mousa, S A., Bozarth, J.M., Forsythe, M.S. et al. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation 1994, 89 (1): 3-12.
7. Newman, W., Dawson, B.L., Carson, C.W. et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in serum of patients with septic shock. J Immunol 1993, 150: 644-54.
8. Gearing, A.J.H., Newman, W. Circulating adhesion molecules in disease. Immunology Today 1993, 14 (10): 506-12.
9. Brandley, B., Swiedler, S., Rabbins, P. Carbohydrate ligands for the LEC cell adhesion molecules. Cell 1990, 63: 861-3.
10. Lasky, L.A., Singer, M., Dowbenko, D. et al. An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 1992, 69. 927-38.
11. Lasky, L.A. Selectins: Interproteins of cell-specific carboyhdrate information during inflammation Science 1992, 258: 964-8.
12. x. Science 1990, 250: 1130-2.
13. Weyrich, A.S., Ma, X-L. Lefer, D.J., Albertine, K.H., Lefer, A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993, 91: 2620-9.
14. Mulligan, M S., Paulson, J.C., De Frees, S. et al. Protective effects of oligo saccharides in P-selectin-dependent lung injury Nature 1993, 364: 149-51.
15. Hullinger, T.G., DeGraaf, G.L., Hartman, J.C., Shebuski, R J The effect of P-selectin blockade on neointimal lesion development in a primate carotid injury model. FASEB 1995, 9: 4897.
16. 1 integrin. Nature 1992, 356: 63-6.
17. Luscinskas, F.W., Brock, A.F., Aranont, M.A. et al. Endothelial-leukocyte adhesion molecule-1 dependent- and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989, 142: 2257-63
18. Topol, E.J., Califf, R.M., Weisman, H.F. et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994, 343: 881-6
19. Peerlinck, K., De Lepeleire, I., Goldberg, M et al, MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation 1993, 88: 1512-7.
20. Barrett, J., Edwards, S., Harris, T et al. The development of a technetium-99m agent for imaging deep vein thrombosis. In: Technetium and Rhenium In Chemistry and Nuclear Medicine. Nicolini, M. et al. (Eds.). S.G. Editoriali: Padova 1995, 275-80.
21. 3 for angiogenesis. Science 1994, 264: 569-71.
22. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79: 1157-64.
23. Davies, J., Warwick, J., Totty, N., Philp, R., Helfich, M., Horton, M The osteoclast functional antigen, implicated in regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989, 109: 1817-26.
24. Horton, M.A., Taylor, M.L , Arnett, T.R., Hetfrich, M.H. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 1991, 195. 368-75.
25. 3 integrin. Exp Cell Res 1994, 214: 459-64.
26. Liaw, L., Skiner, M.P., Raines, E.W. et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 1995, 95: 713-24.
27. Flavin, T., Rothlein, R., Faanes, R., Ivens, K., Starnes, V.A. Monoclonal antibody against intercellular adhesion molecule (ICAM)-1 prolongs cardiac allograft survival in cynomologus monkey. Transplant Proc 1991, 23: 533-4.
28. Haug, C.E., Colvin, R.B., Delmonico, F.L. et al. A phase I trial of immunosuppresston with anti-ICAM-1 (CD54) mAb in renal allograft recipient. Transplantation 1993, 55 (4): 766-73.